Oral vs Intravenous Antibiotics for Fracture-Related Infections: The POvIV Randomized Clinical Trial.
Major Extremity Trauma Research Consortium (METRC); Obremskey WT, O'Toole RV, Morshed S, Tornetta P 3rd, Murray CK, Jones CB, Scharfstein DO, Taylor TJ, Carlini AR, DeSanto JM, Castillo RC, Bosse MJ, Karunakar MA, Seymour RB, Sims SH, Weinrib DA, Churchill C, Carroll EA, Pilson HT, Goodman JB, Holden MB, Miller AN, Sietsema DL, Stahel PF, Mir H, Schmidt AH, Westberg JR, Mullis B, Shively KD, Hymes RA, Konda SR, Vallier HA, Breslin MA, Smith CS, Crickard CV, Egol KA, Reid JS, Baker M, Eglseder WA, LeBrun C, Manson T, Mascarenhas DC, Nascone J, Pollak AN, Schloss MG, Sciadini MF, Degani Y, Miclau T, Weiss DB, Yarboro SR, McVey ED, Firoozabadi R, Agel J, Whiting PS, Haleem A, Domes C, Lang GJ, Kuhn GR, Archer KR, Talbot T, Burgos EJ, Gajari V, Herrera LN, Rodriguez-Buitrago A, Tummuru RR, Abraham CM, Trochez KM.
Major Extremity Trauma Research Consortium (METRC), et al. Among authors: mir h.
JAMA Surg. 2025 Mar 1;160(3):276-284. doi: 10.1001/jamasurg.2024.6439.
JAMA Surg. 2025.
PMID: 39841468
Free PMC article.
Clinical Trial.